Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cian HealthcareBOM:542678 49 Days Inventory is 211.31 as of Mar. 2026, which is 12% below its 10-year median of 239.79. GuruFocus rates BOM:542678 with a GF Score™ of 49/100 and a GF Value™ of ₹82.33 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 920 Drug Manufacturers companies, Cian Healthcare ranks worse than 83.8% on this metric.
The historical rank and industry rank for Cian Healthcare's Days Inventory or its related term are showing as below:
BOM:542678'
s Days Inventory Range Over the Past 10 Years
Min: 127.09 Med: 239.79 Max: 539.07
Current: 292.52
During the past 11 years, Cian Healthcare's highest Days Inventory was 539.07. The lowest was 127.09. And the median was 239.79.
BOM:542678's Days Inventory is ranked worse than 83.8% of 920
companies
in the Drug Manufacturers industry
Industry Median: 165.11
vs BOM:542678: 292.52
Cian Healthcare's Days Inventory
declined
from Mar. 2025 (461.17) to Mar. 2026 (211.31).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Cian Healthcare's Inventory Turnover for the
six
months ended in Mar. 2026 was 0.86.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cian Healthcare's Inventory-to-Revenue for the
six
months ended in Mar. 2026 was 0.83.
Cian Healthcare (BOM:542678) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Cian Healthcare's Inventory Turnover for the
six
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cian Healthcare's Inventory to Revenue for the
six
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Cian Healthcare Days Inventory Related Terms
Cian Healthcare Days Inventory Historical Data
* Premium members only.
The historical data trend for Cian Healthcare's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:542678 vs ZTS, UTHR, VTRS: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Cian Healthcare's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cian Healthcare Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cian Healthcare's Days Inventory distribution charts can be found below:
* The bar in red indicates where Cian Healthcare's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cian Healthcare (BOM:542678) has a Days Inventory of 211.31 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Cian Healthcare and its competitors. This is 12% below median its historical median of 239.79. Over the past decade, Cian Healthcare's Days Inventory has ranged from 127.09 to 539.07. According to the industry distribution chart, Cian Healthcare ranks #771 out of 920 companies in the Drug Manufacturers industry, placing it in the top 83.8%.
Is Cian Healthcare's Days Inventory too high?
Cian Healthcare's current Days Inventory of 211.31 is 12% below median its 10-year median of 239.79. Over the past 10 years, this metric has ranged from a low of 127.09 to a high of 539.07. The Drug Manufacturers industry median Days Inventory is 165.11. Cian Healthcare's value of 211.31 is 28% above this industry median. Based on the distribution chart, Cian Healthcare ranks #771 out of 920 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Cian Healthcare has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cian Healthcare's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Cian Healthcare ranks #771 out of 920 companies for Days Inventory. This places Cian Healthcare in the lower half of its industry. The industry median Days Inventory is 165.11. Cian Healthcare's value of 211.31 is 28% above this benchmark. Historically, Cian Healthcare's own Days Inventory has ranged from 127.09 to 539.07 over the past decade. While the company's 10-year median is 239.79 vs. the industry median of 165.11, Cian Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 165.11, based on 920 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cian Healthcare's current Days Inventory of 211.31 is 28% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Cian Healthcare and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 165.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cian Healthcare's current Days Inventory is 211.31, which is 12% below median its own 10-year median of 239.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cian Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Cian Healthcare (BOM:542678) is currently considered Possible Value Trap. The stock's GF Value™ is ₹82.33, compared to a current price of ₹9.55 — trading 88.4% below its estimated fair value. The current Days Inventory is 211.31, which is 12% below median its 10-year median of 239.79 and 28% above the Drug Manufacturers industry median of 165.11. Cian Healthcare's overall GF Score™ is 49/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Cian Healthcare (BOM:542678), the current Days Inventory is 211.31 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cian Healthcare (BOM:542678) Overvalued in 2026?
Based on GuruFocus' analysis, Cian Healthcare stock appears to be undervalued.
The current stock price of ₹9.55 is trading 88.4% below its estimated GF Value™ of ₹82.33.
GuruFocus considers Cian Healthcare to be Possible Value Trap.
Key valuation signals for BOM:542678:
Days Inventory: 211.31 (12% below median its 10-year median of 239.79)
GF Value™: ₹82.33 vs. price of ₹9.55 (88.4% below fair value)
Industry Position: 28% above the Drug Manufacturers median (#771 of 920)
No single metric tells the full story. See the BOM:542678 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cian Healthcare Ltd is a fully integrated pharmaceutical company engaged in the research, development, manufacturing, and marketing of pharmaceutical products. The company manufactures multiple product lines, including tablets, capsules, soft gels, liquid orals, ointments/creams and sachets, and cosmetics. Its portfolio comprises gynecology, haematinic, cardio-diabetic, orthopedic, pediatric, dermacosmetic, antibiotic, CNS, vitamins, and nutrient products. The company operates in five sectors: Export, Government Supplies, Merchant Export, Own Brand Franchise Business, and Third Party/Contract Manufacturing.
49GF Score
Get the complete analysis for BOM:542678
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:542678 has been successfully added to your 
